Cerebra Integrated Technologies Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
CEREBRAINT · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Cerebra Integrated Technologies submitted its unaudited financial results for Q3 FY26 (quarter ended Dec 31, 2025) and the nine months ended Dec 31, 2025. Revenue collapsed sharply — Q3 revenue fell to just Rs. 81.52 lakhs from Rs. 1,073.72 lakhs in Q3 FY25 (roughly a 92% drop), while 9-month revenue declined to Rs. 4.81 crore from Rs. 33.09 crore. The company reported a 9-month loss of Rs. 40.49 crore, slightly wider than Rs. 39.54 crore in the same period last year. An exceptional item of Rs. 9.76 crore was booked as inventory devaluation. The auditor, YCRJ & Associates, issued a 'Disclaimer of Conclusion' on both standalone and consolidated results, flagging serious concerns including Rs. 142.49 crore in trade receivables (Rs. 141.25 crore overdue over a year), Rs. 100.28 crore receivable from a Dubai entity overdue 2+ years, unconfirmed capital advances of Rs. 20.29 crore, and a subsidiary (Cerebra LPO India) whose net worth is fully eroded with material uncertainty over its ability to continue as a going concern.
This is a deeply negative filing for shareholders. The revenue collapse, widening losses, and auditor's disclaimer together with going-concern doubts at the subsidiary point to severe financial distress. Expect significant negative reaction in the stock price and heightened scrutiny on recoverability of the large overdue receivables.